Publications & Resources
Get insights and guidance from MLMIC and other leading sources on medical professional liability, risk management, and more.
Tag: risk management
Updated CDC Guidance for COVID-19 Infection Control
Updated COVID-19 infection control recommendations issued by the Centers for Disease Control and Prevention can help reduce risk to medical facilities and its healthcare personnel.
Clinical Practice Recommendations to Help Treat IBD Patients During the COVID-19 Emergency
New recommendations issued by the American Gastroenterological Association offer clinical practice guidelines for treating inflammatory bowel disease patients during the COVID-19 emergency.
New research indicates there is weak evidence that chloroquine, hydroxychloroquine and azithromycin can effectively treat and prevent COVID-19 and the drugs carry potentially serious risks.
New York Public Health Law Provides Immunity for Facilities and Professionals Responding to COVID-19
New York has enacted the Emergency Disaster Treatment Protection Act, a new statute in the Public Health Law that provides healthcare facilities and professionals immunity from civil or criminal liability when delivering care related to COVID-19.
A new Executive Order issued by New York Governor Cuomo continues certain healthcare and malpractice liability directives outlined in previous Executive Orders that address the COVID-19 pandemic.
Evidence-Based Recommendations to Help Care for COVID-19 Patients in the ICU
New recommendations issued by an international research team offer clinical practice guidelines for physicians treating intensive care unit patients with COVID-19.
Mitigating Cybersecurity Threats During the COVID-19 Pandemic
Experts caution hospitals and healthcare organizations about an increased risk of cyberattacks during the COVID-19 emergency.
Legal Risks and Tips for Volunteer Physicians During the COVID-19 Pandemic
MLMIC’s tips and legal risks for policyholders to consider when volunteering during the COVID-19 pandemic.
Experts Say There is No Evidence NSAIDs are Unsafe for COVID-19 Patients
New research refutes speculation that NSAIDs can negatively impact patients with COVID-19.
When Appropriate, FDA Permits Use of Hydroxychloroquine and Chloroquine to Treat COVID-19
The FDA issued emergency use authorization for anti-malarial drugs hydroxychloroquine and chloroquine to treat COVID-19 patients when deemed appropriate by a healthcare provider.